Stonepine Capital Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-152,278
| Closed | -$1.64M | – | 25 |
|
|
2022
Q3 | $1.64M | Hold |
152,278
| – | – | 0.74% | 17 |
|
|
2022
Q2 | $1.83M | Buy |
+152,278
| New | +$1.83M | 0.85% | 19 |
|
|
2020
Q2 | – | Sell |
-380,948
| Closed | -$3.65M | – | 19 |
|
|
2020
Q1 | $3.65M | Buy |
380,948
+46,676
| +14% | +$447K | 3.86% | 9 |
|
|
2019
Q4 | $4.81M | Buy |
334,272
+20,199
| +6% | +$291K | 3.36% | 9 |
|
|
2019
Q3 | $4.73M | Sell |
314,073
-1,395
| -0.4% | -$21K | 4.59% | 8 |
|
|
2019
Q2 | $4.18M | Buy |
315,468
+20,574
| +7% | +$273K | 2.88% | 13 |
|
|
2019
Q1 | $3.87M | Sell |
294,894
-63,066
| -18% | -$827K | 2.23% | 15 |
|
|
2018
Q4 | $5.17M | Buy |
357,960
+172,073
| +93% | +$2.49M | 4.54% | 9 |
|
|
2018
Q3 | $3.32M | Buy |
+185,887
| New | +$3.32M | 1.94% | 15 |
|